breast cancer
Conditions
Interventions
study group:Before operation, the patients were given methylene blue dye and RESOVIST injection combined with magnetic detector in vitro for signal collection.
study group:After neoadjuvant therapy, the patients in a lower stage were given methylene blue dye and RESOVIST injection combined with magnetic detector in vitro for signal collection.
Sponsors
the First Affiliated Hospital of China Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1)adult women aged 18-75 years,patients with axillary node-negative early breast cancer planned for Sentinel lymph node biopsy; (2)adult women aged 18-75 years,patients with locally advanced breast cancer who completed a full course of neoadjuvant therapy had negative axillary downgrade and planned for Sentinel lymph node biopsy.
Exclusion criteria
Exclusion criteria: (1) intolerance or hypersensitivity to iron or glucose, (2) pregnancy or lactation, (3) pacemaker or other iron-containing device on chest wall; (4) liver failure or renal failure (creatinine =1.1, AST =50, ALT =40, T-bil =1.5).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate per case; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lymph node detection rate;Malignant tumor rate; | — |
Countries
China
Contacts
Public ContactLina Zhang
the First Affiliated Hospital of China Medical University
Outcome results
None listed